With nearly $3.4B raised, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies, focusing on Life Sciences and Growth Buyout investments.

Life Sciences

Acquired by AstraZeneca in 2016
IPO in 2017 (NASDAQ: ANAB)
Acquired by Valeant Pharmaceuticals in 2014
Acquired by Allergan in 2016

Growth Buyout

Acquired by McKesson Corporation
Acquired by The Partners Group


Frazier Healthcare Partners

Frazier Healthcare Partners Closes Oversubscribed $419 Million Life Sciences Fund

Southside Pharmacy

Frazier Healthcare Growth Buyout Acquires New Specialty Pharma Platform


Roche and Ignyta Reach Definitive Merger Agreement

Vein Clinics of America

Frazier Healthcare Growth Buyout Acquires Vein Clinic Platform